🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Drugs used in chemotherapy, such as 3-AP and cisplatin, work in different w...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2004-01
Trial ID
NCT00077545
RATIONALE: Drugs used in chemotherapy, such as 3-AP and gemcitabine, work i...
Status
Completed
Location
Sydney Cancer Centre at Royal Prince Alfred Hospital
Start Date
2004-04
Trial ID
NCT00077415
Treatments Being Tested
The goal of this clinical trial is to investigate the safety and efficacy o...
Status
Recruiting
Location
KGK Science Inc.
Start Date
2026-06
Trial ID
NCT07388043
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy such as gemcitabine use different way...
Status
Completed
Location
University of Chicago Cancer Research Center
Start Date
2003-01
Trial ID
NCT00064064
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of triapin...
Status
Recruiting
Location
Northwestern University
Start Date
2024-07-23
Trial ID
NCT06410248
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
New York Presbyterian Hospital - Cornell Campus
Start Date
2000-12
Trial ID
NCT00016874
Treatments Being Tested
Drugs used in chemotherapy, such as 3-AP and gemcitabine, work in different...
Status
Completed
Location
Eastern Cooperative Oncology Group
Start Date
2004-07
Trial ID
NCT00077350
Treatments Being Tested
This randomized phase III trial studies radiation therapy and cisplatin wit...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-05-10
Trial ID
NCT02466971
RATIONALE: Drugs used in chemotherapy, such as 3-AP and gemcitabine, work i...
Status
Completed
Location
Margaret and Charles Juravinski Cancer Centre
Start Date
2004-04
Trial ID
NCT00078975
Treatments Being Tested
This phase I trial is studying the best dose of 3-AP and the side effects o...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2006-06
Trial ID
NCT00293345
Treatments Being Tested